- Home
- BOF vs ONCO Comparison
BOF vs ONCO Comparison
Compare BOF & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- ONCO
- Stock Information
- Founded
- BOF 2017
- ONCO 2018
- Country
- BOF United States
- ONCO United States
- Employees
- BOF N/A
- ONCO N/A
- Industry
- BOF Packaged Foods
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- BOF Consumer Staples
- ONCO Health Care
- Exchange
- BOF Nasdaq
- ONCO Nasdaq
- Market Cap
- BOF 15.1M
- ONCO 4.6M
- IPO Year
- BOF 2023
- ONCO 2022
- Fundamental
- Price
- BOF $1.80
- ONCO $0.56
- Analyst Decision
- BOF
- ONCO
- Analyst Count
- BOF 0
- ONCO 0
- Target Price
- BOF N/A
- ONCO N/A
- AVG Volume (30 Days)
- BOF 121.1K
- ONCO 17.1M
- Earning Date
- BOF 11-14-2024
- ONCO 12-10-2024
- Dividend Yield
- BOF N/A
- ONCO N/A
- EPS Growth
- BOF N/A
- ONCO N/A
- EPS
- BOF N/A
- ONCO N/A
- Revenue
- BOF $6,489,951.00
- ONCO $1,870,605.00
- Revenue This Year
- BOF N/A
- ONCO N/A
- Revenue Next Year
- BOF N/A
- ONCO N/A
- P/E Ratio
- BOF N/A
- ONCO N/A
- Revenue Growth
- BOF 372.36
- ONCO N/A
- 52 Week Low
- BOF $0.61
- ONCO $0.32
- 52 Week High
- BOF $4.11
- ONCO $21.40
- Technical
- Relative Strength Index (RSI)
- BOF 52.41
- ONCO 44.15
- Support Level
- BOF $1.53
- ONCO $0.46
- Resistance Level
- BOF $2.08
- ONCO $0.76
- Average True Range (ATR)
- BOF 0.16
- ONCO 0.22
- MACD
- BOF -0.00
- ONCO 0.08
- Stochastic Oscillator
- BOF 49.09
- ONCO 15.93
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.